electroCore (ECOR) Other financing activities (2017 - 2026)

electroCore's (ECOR) quarterly Other financing activities came in at $223000.0 in Q1 2026, up 22200.0% year-on-year from N/an in Q1 2025, and up 606.82% quarter-over-quarter from -$44000.0 in Q3 2025.

electroCore (ECOR) Other financing activities (2017 - 2026) Analysis & Trends

electroCore's Other financing activities history runs 3 years deep, the most recent figure standing at $223000.0 for Q1 2026.

  • On a quarterly basis, Other financing activities rose 22200.0% year-over-year to $223000.0 in Q1 2026; TTM through Mar 2026 was $223000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1000.0, down 99.73% from the prior year.
  • Other financing activities advanced to $223000.0 in Q1 2026 per ECOR's latest filing, from -$44000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $223000.0 in Q1 2026 and bottomed at -$44000.0 in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 electroCore 56,941.08 -8.77 Mn 8.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 223,000.00
Mar 31, 2026 223,000.00
Sep 30, 2025 -44,000.00
Sep 30, 2025 -44,000.00
Jun 30, 2025 44,000.00
Jun 30, 2025 44,000.00
Mar 31, 2025 1,000.00
Mar 31, 2025 1,000.00
Dec 31, 2017 373,304.00
Dec 31, 2017 373,304.00
Sep 30, 2017 -232,845.00
Sep 30, 2017 -232,845.00